Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Hans Peter Lohrmann"'
Publikováno v:
Scandinavian Journal of Haematology. 28:151-162
In order to describe the changes of the human bone marrow compartments after repeated courses of adriamycin/cyclophosphamide in quantitative terms, 2 methods have been studied for their usefulness as indices of bone marrow cellularity: cell counts pe
Autor:
Hans Walter Lindemann, M. Frick, Karin Burock, Bernd Metzner, Oleg Gluz, Carl Richard Meier, H.-H. Wolf, Axel R. Zander, M Hänel, Andreas Neubauer, Christian Jackisch, Gerhard Ehninger, Hans Peter Lohrmann, Kathrin Kolbe, Ute Ruffert, Heinrich Bodenstein, Yon Ko, Ulrike Nitz, Svjetlana Mohrmann, Nicolaus Kröger
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(24)
Purpose To compare progression-free survival between single and tandem high-dose chemotherapy (HDT) followed by autologous stem-cell transplantation in chemotherapy-sensitive metastatic breast cancer patients. Patients and Methods Between February 19
Autor:
Shraga F. Goldmann, Hans-Peter Lohrmann, Tom Kristensen, M. Dietrich, Claus Abt, Theodor M. Fliedner, Hermann Heimpel, Hans-Dieter Flad, H Pflieger, Bernhard Kubanek
Publikováno v:
Blut Zeitschrift für die Gesamte Blutforschung. 31:347-354
Bone-marrow transplantation (BMT) from an unrelated, HL-A-phenotype-identical, MLC-negative donor was performed in a 31 year old woman with severe longlasting aplastic anemia. In vitro assays failed to demonstrate humoral or cellular sensitization of
Autor:
Hans-Peter Lohrmann
Publikováno v:
Klinische Wochenschrift. 52:1143-1150
Klinische Befunde der bei metastasierenden Carcinomen gelegentlich auftretenden mikroangiopathischen hamolytischen Anamie werden besprochen und pathophysiologische Zusammenhange dargestellt. Gesteigerte intravasale Gerinnung, die klinisch haufig nur
Autor:
M. Betzler, Hermann Heimpel, W. Schreml, Peter M. Schlag, Hans-Peter Lohrmann, M. Lang, Christian Herfarth
Publikováno v:
European Journal of Cancer and Clinical Oncology. 19:607-613
In a phase II-type study 52 patients with no signs of metastases but with a high risk of recurrence were treated with 6 courses of adriamycin-cyclophosphamide as adjuvent systemic therapy following modified radical mastectomy of primary breast cancer
Publikováno v:
Klinische Wochenschrift. 53:595-603
Supportive care with blood component transfusions has greatly improved prognosis in patients with bone marrow failure. This progress has made possible by newly developed techniques for separation of blood cells and by a better understanding of the an
Autor:
Hans-Peter Lohrmann, P. Wernet
Publikováno v:
Blut. 37:43-46
Publikováno v:
Journal of Experimental Medicine. 139:1037-1048
Lymphocytes, stimulated with different doses of plant mitogens or allogeneic cells, incorporate varying amounts of [3H]thymidine. Theoretically, this may be due to different numbers of responding cells, to earlier proliferative response of these cell
Publikováno v:
Blut. 38:9-16
The reaction pattern of an unperturbed human granulopoiesis to pulses of high-dose chemotherapy (cyclophosphamide 2000 mg/m2 plus vincristine 1.4 mg/m2 or adriamycin 20 mg/m2) was serially studied in 6 patients. The stem cells committed to granulopoi